Answers are grounded in this paper and cite their sources.
Deferred revascularization may benefit selected fragile ACS shock patients; hypothesis-generating from Level 5 data and leaves open need for RCTs.
Cardiogenic shock (CS) complicating acute coronary syndrome (ACS) remains associated with high mortality despite advances in medical therapy, percutaneous coronary intervention (PCI), and mechanical circulatory support. Urgent culprit-lesion PCI remains the established strategy in ST-segment elevation myocardial infarction (STEMI)-related CS; however, ACS-related CS is heterogeneous, and the net benefit of immediate revascularization may not be uniform, particularly in clinically fragile patients. This comprehensive review summarizes current guideline recommendations and contemporary evidence concerning medical and hemodynamic support, PCI strategies, and selective mechanical circulatory support use in ACS-related CS without mechanical complications. We also examine observational studies that included non-reperfusion cohorts, in which invasive management was deferred because of adverse clinical features or procedural infeasibility. Although these studies do not establish the superiority of conservative treatment, they demonstrate clinical settings in which stabilization without immediate PCI has been used. Experimental and pathophysiological evidence concerning ischemia/reperfusion injury, ischemic preconditioning, myocardial stunning, hibernation, and low cardiac output syndrome after coronary artery bypass grafting suggests that abrupt reperfusion may further impair myocardial function in susceptible patients. We therefore propose that a stabilization-focused conservative strategy with individualized revascularization decisions warrants prospective evaluation across a broad spectrum of patients with ACS-related CS, including selected patients with STEMI-CS. This hypothesis does not support routinely withholding PCI but highlights the need to determine which patients may benefit from delayed rather than immediate revascularization.
No takes yet. Share an insight, caveat, or question.
Gencer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: